Brief: Scynexis Reports Third Quarter 2022 Financial Results
Nov 9 (Reuters) - Scynexis Inc SCYX.O :
* SCYNEXIS REPORTS THIRD QUARTER 2022 FINANCIAL RESULTS AND
PROVIDES CORPORATE UPDATE
* Q3 SALES $1.6 MILLION
* SCYNEXIS - SCYNEXIS ENDED Q3 WITH A CASH, CASH EQUIVALENTS
AND
SHORT-TERM INVESTMENT BALANCE OF $96.1 MILLION AND HAS A
PROJECTED CASH RUNWAY INTO Q2 2024
* QTRLY LOSS PER SHARE $0.62
* QTRLY TOTAL REVENUE $1.6 MILLION VERSUS $0.5 MILLION
* Q3 EARNINGS PER SHARE VIEW $-0.50, REVENUE VIEW $2.1
MILLION --
REFINITIV IBES DATA
Source text for Eikon: ID:nGNXb5sy2t
Further company coverage: SCYX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Scynexis
See all newsBrief: Scynexis Announces Phase 1 Study Results For Scy-770, A Novel, Highly Selective, Oral Direct Ampk Activator For The Treatment Of Autosomal Dominant Polycystic Kidney Disease
Brief: Scynexis Announces Appointment Of Sanjay Subramanian As Chief Financial Officer
Scynexis Inc Reports Results For The Quarter Ended June 30: Earnings Summary
Scynexis Q2 swings to profit on warrant adjustment; advances drug studies
Scynexis Inc Expected To Post A Loss Of 51 Cents A Share: Earnings Preview